Condition

Minimal Residual Disease Positive AML (1)

Myelodysplastic Syndrome (1)

Relapsed/Refractory AML (1)

Overall Status

Terminated (1)

Sign in for free

Phase

phase 1 (1)

Sponsor

Amgen (1)

Collaborator

Intervention

amg 330 (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Industry (1)

Study Type

Interventional (1)

minimal residual disease positive aml

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Relapsed/Refractory AML, Minimal Residual Disease Positive AML, Myelodysplastic Syndrome Trial in Worldwide (AMG 330)

Terminated

Relapsed/Refractory AML
+2 more

AMG 330

Birmingham, Alabama
+10 more

Nov 9, 2022